a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets
Industry Biotechnology
A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with PRME. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then PRME could also see price increases.
Ticker / NAME | Correlation To RLAY | 1D Price Change % | ||
---|---|---|---|---|
RLAY | 100% | -4.71% | ||
PRME - RLAY | 51% Loosely correlated | -9.81% | ||
NTLA - RLAY | 51% Loosely correlated | -3.65% | ||
SNDX - RLAY | 49% Loosely correlated | -0.05% | ||
OMER - RLAY | 48% Loosely correlated | -5.70% | ||
XNCR - RLAY | 47% Loosely correlated | -3.14% | ||
More |
Ticker / NAME | Correlation To RLAY | 1D Price Change % |
---|---|---|
RLAY | 100% | -4.71% |
therapeutics theme (57 stocks) | 47% Loosely correlated | +20.54% |